NFKB1 and inflammatory bowel disease: The activity of B1 toward inhibition of p65/NF-κB-dependent gene transcription in HeLa cells was comparable to Sulfasalazine, an anti-inflammatory agent used in the management of inflammatory bowel disease and rheumatoid arthritis (Supplementary Figure S4).